Abstract
There is evidence of neutrophil involvement in the pathogenesis of the haemolytic uraemic syndrome (HUS), and neutrophil release products are thought to cause endothelial cell damage. Elastase is the major lysosmal proteinase liberated by activated neutrophils. In this study we measured both free and complexed elastase. No free elastase activity could be detected in the plasma of patients with diarrhoea-associated (D+) HUS using a specific substrate. However, there was a marked increase in α1-antitrypsin (α1-AT) complexed elastase as measured by a newly developed enzyme-linked immunosorbent assay not only in D+ HUS, but also in non-diarrhoea-associated (D-) HUS. This finding is independent of either a high polymorphonuclear leucocyte count or renal failure. This increase in bound elastase together with our sequential data which demonstrate raised α1-AT complexed elastase levels early in the disease process further support the theory that neutrophil activation is one of the key events in the pathophysiology of this disorder.
Similar content being viewed by others
References
Fong JSC, De Chadarevian JP, Kaplan BS (1982) Hemolytic uremic syndrome: current concepts and management. Pediatr Clin North Am 29:835–856
Kaplan BS, Thompson PD, De Chadarevian JP (1976) The hemolytic uremic syndrome. Pediatr Clin North Am:761–777
Levin M, Barratt TM (1984) Haemolytic uraemic syndrome. Arch Dis Child 59:397–400
Gianantonio CA, Vitacco M, Mendiharzu F, Rutty A, Mendilharzu J (1964) The hemolytic uremic syndrome. J Pediatr 4:478–491
Piel CF, Phibbs RH (1966) The hemolytic uremic syndrome. Pediatr Clin North Am 13:295–314
Koster F, Levin J, Walker L (1978) Hemolytic uremic syndrome after shigellosis: relation to endotoxaemia and circulating immune complexes. N Engl J Med 298:927–933
Walters MDS, Matthei IU, Kay R, Dillon MJ, Barratt TM (1989) Polymorphonuclear leucocyte count in haemolytic uraemic syndrome. Pediatr Nephrol 3:130–134
Robson WL, Fick GH, Wilson PC (1988–1989) Prognostic factors in typical post-diarrhea hemolytic-uremic syndrome. Child Nephrol Urol 9:203–207
Harlan JM, Killen PD, Harler LA, Striker GE (1981) Neutrophil mediated endothelial injury in vitro. J Clin Invest 68:1394–1403
Vedanaraynanan W, Kaplan BS, Fong BSC (1987) Neutrophil function in an experimental model of hemolytic uremic syndrome. Pediatr Res 21:252–256
Forsyth KD, Simpson AC, Fitzpatrick MM, Barratt TM, Levinsky RJ (1989) Neutrophil mediated endothelial injury in haemolytic uraemic syndrome. Lancet II:411–414
Kaplan BS, Mills M (1988) Elevated serum elastase and α1-antitrypsin levels in haemolytic uraemic syndrome. Clin Nephrol 30: 193–196
Henson PM, Johnston RB (1987) Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J Clin Invest 79: 669–674
Carrel RW (1986) Alpha-1-antitrypsin: molecular pathology, leucocyte and tissue damage. J Clin Invest 78:1427–1431
Worthen GS, Haslett C, Rees AJ, Gumbay RS, Henson JE, Henson PM (1987) Neutrophil mediated pulmonary vascular injury. Am Rev Respir Dis 136:19–28
Davies M, Barrett AJ, Travis J, Sanders E, Coles GA (1978) The degradation of human glomerular basement membrane with purified lysosomal proteinases: evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis. Clin Sci Mol Med 54:233–240
Ohlsson K, Olsson I (1977) The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes. Scand J Haematol 19:145–152
Ohlsson K, Olsson I (1974) Neutral proteases of human granulocyte. III. Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest 34:349–355
Brower MS, Harpel PC (1983) Alpha-1-antitrypsin-human leucocyte elastase complexes in blood: quantification by an enzyme linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes. Blood 61:842–849
Johnson RJ, Couser WG, Alpers CE, Vissers M, Schulze M, Klebanoff SJ (1988) The human neutrophil serine proteinases, elastase and cathepsin g, can mediate glomerular injury in vivo. J Exp Med 168:1169–1174
Barrett AJ (1981) Leucocyte elastase. In: Lorand L (ed) Methods in enzymology, vol 80. Academic Press, New York, pp 581–584
Karmali MA, Steele BT, Petric M, Lim C (1983) Sporadic cases of haemolytic uraemic syndrome associated with faecal cytotoxin and cytotoxin producingEscherichia coli in stools. Lancet I:619–620
Grandsen WR, Damm MAS, Anderson JD (1986) Further evidence associating hemolytic uremic syndrome with infection by verotoxin producingEscherichia coli 0157: H7. J Infect Dis 155:522–524
Carter AO, Borczyk AA, Carlson JAK (1987) An outbreak ofEscherichia coli 0157:H7-associated haemorrhagic colitis in a nursing home. N Engl J Med 317:1496–1500
Smedley LA, Tonnesen MG, Sandhaus RA, Haslet C, Guthrie LA, Johnson PM, Henson PM, Worthen GS (1986) Neutrophil-mediated injury to endothelial cells. J Clin Invest 77:1233–1243
Butler T, Islam MR, Azad MAK, Jones PK (1987) Risk factors for the development of hemolytic uremic syndrome during shigellosis. J Pediatr 110:894–897
Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, Ross Boswell D (1982) Structure and variation of human α1-antitrypsin. Nature 298:329–334
Milford D, Taylor CM, Rafaat F, Halloran E, Daws J (1989) Neutrophil elastases and haemolytic uraemic syndrome (letter). Lancet II: 1153
Bergstein JM, Kuerderli U, Bang NU (1982) Plasma inhibitor of glomerular fibrinolysis in the haemolytic uraemic syndrome. Am J Med 73:322–327
Coad NAG, Marshall T, Rowe B, Taylor CM (1991) Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol 35:10–16
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fitzpatrick, M.M., Shah, V., Filler, G. et al. Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma. Pediatr Nephrol 6, 50–53 (1992). https://doi.org/10.1007/BF00856833
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00856833